Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers to continue to explore the world of gut microbiota.
The annual call for proposals is carried out in countries where Biocodex has a subsidiary presence. An independent local scientific committee – made up of individuals recognized for their expertise in the microbiota field – gathers all proposals and selects the winning project to be granted.
Biocodex Microbiota Foundation in collaboration with Biocodex Microbiota Institute put national winners in the spotlight through testimonies and interviews!
Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers.
Granted projects
2022
Influence of gut microbiota composition and function on acute and persistent post-surgical pain
Mycobiota METabolism Adenosine for Obesity – MMETA4Obesity
Assessment of the intestinal microbiome enterotype and the ability to break down starch in a weight reduction program using nutritional intervention and probiotic therapy in obese women
Evolution of the intestinal microbiome, inflammatory markers, and body composition across lactation stages in infants born to women with normal weight and overweight/obesity
Evaluating accumulative effect of antidepressants usage on the gut microbiome
Does microbiome composition moderate CNS structure and function in a VPA-induced mouse model of autism?
Improving the efficacy of L-dopa therapy of Parkinson’s disease through inhibiting L-dopa conversion to dopamine by intestinal bacteria
Role of the Type VI Secretion System (T6SS) of Pathogenic Enterobacteriaceae in the displacement of the microbiota that could lead to intestinal dysbiosis
2021
Does immunosuppression contribute to metabolic syndrome via the intestinale microbiome?